Stay updated on IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.

Latest updates to the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page
- Check2 days agoChange DetectedA new revision entry labeled v3.6.3 was added to the Study Record History, and the previous v3.6.2 entry was removed. This reflects an update to the page's revision history in the study's record.SummaryDifference0.1%

- Check9 days agoChange DetectedA new revision entry 'Revision: v3.6.2' was added to the history and the previous 'Revision: v3.6.0' was removed. This reflects an update to the page's revision metadata.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedRecruitment status updated to no longer look for participants, indicating enrollment is closed. The record history shows a new Revision: v3.6.0 and the removal of Revision: v3.5.5.SummaryDifference0.4%

- Check31 days agoChange DetectedA new revision label, v3.5.5, is now shown in the page history, replacing the previous v3.5.4. This indicates an internal update to the page's revision tracking.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now shows a revision label of v3.5.4, replacing the previous v3.5.3 in the Record History. This reflects a minor update to the page's revision metadata.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision label has been updated from v3.5.2 to v3.5.3, indicating a new software release. No study-specific details on the record history table appear to be changed.SummaryDifference0.1%

Stay in the know with updates to IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 Enhancing Anti-PD-1 in Melanoma Clinical Trial page.